Markets:

Overview

News

Currencies

International

Treasuries

Arrowhead Pharmaceuticals, Inc. - Common Stock (NQ:ARWR)

63.82 +1.44 (+2.31%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Arrowhead Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Analyst Ratings for Arrowhead Pharma ↗

March 21, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023 ↗

March 21, 2023

Via Benzinga

JNJ Terminates NASH Program Pact With Arrowhead Pharmaceuticals ↗

February 15, 2023

Via Benzinga

Arrowhead Pharmaceuticals's Return On Capital Employed Overview ↗

February 07, 2023

Via Benzinga

Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 06, 2023

Gainers Secoo Holding Limited (NASDAQ: SECO) jumped 156% to $4.3600. Arqit Quantum Inc. (NASDAQ: ARQQ) gained 41.5% to $3.54.

Via Benzinga

Energizer, Children's Place And Other Big Stocks Moving Lower On Monday ↗

February 06, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Earnings Scheduled For February 6, 2023 ↗

February 06, 2023

Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion.

Via Benzinga

Earnings Outlook For Arrowhead Pharmaceuticals ↗

February 03, 2023

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Arrowhead Pharmaceuticals: Here's What You Need To Know ↗

December 06, 2022

Via Benzinga

Arrowhead Pharmaceuticals's Return On Capital Employed Overview ↗

November 29, 2022

Via Benzinga

Analyst Ratings for Arrowhead Pharmaceuticals ↗

November 29, 2022

Via Benzinga

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 09, 2023

Via Benzinga

Earnings Preview For Arrowhead Pharmaceuticals ↗

November 25, 2022

Via Benzinga

Arrowhead Pharmaceuticals Reports Underwhelming Data From Inherited Disease Study ↗

January 09, 2023

Via Benzinga

Why Arrowhead Pharmaceuticals Stock Is Diving Today ↗

January 09, 2023

Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) shares are down 20% Monday after the company announced topline results from the SEQUOIA Phase 2 study of fazirsiran in patients with

Via Benzinga

CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks ↗

January 06, 2023

Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.

Via Investor's Business Daily

Arrowhead Pharmaceuticals Surges After Hinting At A Midstage Win In Liver Disease ↗

November 29, 2022

The company says it plans soon to present Phase 2 results and its Phase 3 study design.

Via Investor's Business Daily

Earnings Scheduled For November 28, 2022 ↗

November 28, 2022

Companies Reporting Before The Bell • Pinduoduo (NASDAQ:PDD) is projected to report quarterly earnings at $0.65 per share on revenue of $4.31 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗

September 09, 2022

Upgrades

Via Benzinga

What 7 Analyst Ratings Have To Say About Arrowhead Pharmaceuticals ↗

August 08, 2022

Analysts have provided the following ratings for Arrowhead Pharmaceuticals (NASDAQ:ARWR) within the last quarter:

Via Benzinga

Arrowhead Pharmaceuticals: Q3 Earnings Insights ↗

August 04, 2022

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported its Q3 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Where Arrowhead Pharmaceuticals Stands With Analysts ↗

May 24, 2022

Within the last quarter, Arrowhead Pharmaceuticals (NASDAQ:ARWR) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022 ↗

May 11, 2022

Upgrades

Via Benzinga

Arrowhead Pharmaceuticals: Q2 Earnings Insights ↗

May 10, 2022

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported its Q2 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Week In Review: I-Mab Files For Hong Kong SPAC IPO To Acquire Life Science Company ↗

April 30, 2022

I-Mab and one of its investors, VMS, have filed for a Hong Kong IPO of a SPAC that will raise funds to acquire a life science company. Also, RVAC Medicines completed a Series B funding that brings...

Via Talk Markets

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗

April 24, 2022

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 23, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

The Best Russell 2000 Stocks to Buy Before they Rebound ↗

February 15, 2022

Some of the best stocks in the market are among the best Russell 2000 stocks to buy. Here's a list of a few of those choices.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Arrowhead Pharmaceuticals, Inc. - Common Stock (NQ:ARWR)

Headline News about Arrowhead Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today